International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 2063-2067
Original Article
Clinical Spectrum, Severity, and Outcomes of Organophosphorus Compound Poisoning: A Prospective Observational Study at a Tertiary Care Center, HIMS Hassan.
 ,
 ,
 ,
Received
Dec. 8, 2025
Accepted
Dec. 20, 2025
Published
Dec. 31, 2025
Abstract

Background: Organophosphorus (OP) compound poisoning is a major cause of morbidity and mortality in agricultural regions. Early assessment of severity is critical for management and outcome prediction.

Objectives: To evaluate the clinical spectrum, severity, and outcomes of OP poisoning and identify predictors of adverse outcomes.

Methods: A prospective observational study was conducted over 18 months at HIMS Hassan, enrolling 276 adult patients with confirmed OP poisoning. Severity at admission was graded using the Peradeniya Organophosphorus Poisoning (POP) scale. Sample size was calculated based on mortality reported in Kamath SD et al., 2021 (22%). Data included demographics, clinical features, lab findings, POP scores, ventilatory support, complications, hospital stay, and mortality. Statistical analysis included descriptive statistics, χ², t-tests, and logistic regression.

Results: Of 276 patients, 160 (58%) were male; mean age was 32 ± 11 years. Suicidal ingestion accounted for 88%. Common agents were monocrotophos (30%) and chlorpyrifos (25%). Vomiting (88%) and profuse secretions (72%) were frequent. POP grading: mild 38% (105), moderate 43% (119), severe 19% (52). Ventilatory support was required in 45% overall, increasing with severity (mild 12%, moderate 46%, severe 92%; p < 0.001). Overall mortality was 21% (58/276), rising from 4% in mild to 67% in severe cases. Logistic regression identified severe POP score, ventilatory support, and delayed hospital arrival (>6 hrs) as independent predictors of mortality.

Conclusion: POP scale severity at admission strongly correlates with outcomes in OP poisoning. Early recognition and timely intervention can reduce morbidity and mortality.

Keywords
INTRODUCTION

Organophosphorus (OP) compounds are among the most widely used pesticides globally, particularly in developing countries, due to their high efficacy and low cost. These compounds are a major cause of acute poisoning, with an estimated 3 million cases worldwide each year, leading to substantial morbidity and mortality, particularly in rural areas with limited healthcare access.¹

 

OP compounds act primarily through irreversible inhibition of acetylcholinesterase, resulting in accumulation of acetylcholine at synapses and neuromuscular junctions. This causes overstimulation of muscarinic, nicotinic, and central nervous system receptors, leading to classical manifestations such as vomiting, salivation, miosis, fasciculations, seizures, respiratory failure, and death in severe cases.²⁻³

In India, OP poisoning is frequently encountered in emergency departments, often due to suicidal ingestion rather than accidental exposure.⁴ Mortality rates reported in various Indian studies range from 4% to over 30%, influenced by the type and quantity of OP ingested, time to hospital presentation, and availability of intensive care facilities.⁵⁻⁶

 

Early assessment of poisoning severity is crucial for prognostication and management. The Peradeniya Organophosphorus Poisoning (POP) scale, developed in Sri Lanka, uses seven clinical parameters (pulse rate, pupil size, fasciculations, respiratory rate, level of consciousness, seizures, and presence of vomiting or secretions) to classify poisoning as mild, moderate, or severe.⁷ Several studies have demonstrated that POP scores strongly correlate with the need for mechanical ventilation, complications, and mortality.⁸⁻⁹

 

Despite extensive research, there remains regional variation in clinical presentation, agent type, and outcomes, emphasizing the need for local data to guide management strategies. Kamath SD et al., in a prospective study at Tata Main Hospital, reported a 22% mortality rate among 100 patients with OP poisoning and highlighted the predictive value of the POP scale for ventilatory requirement and outcomes.¹⁰

 

This study was conducted at Hassan Institute of Medical Sciences (HIMS), Hassan, to evaluate the clinical spectrum, severity, and outcomes of OP poisoning in adults, using the POP scale to predict adverse outcomes and identify factors associated with increased mortality. This information is intended to inform clinical decision-making and improve patient care in tertiary care settings.

 

Methods

Study Design and Setting

Prospective observational study at HIMS Hassan, a tertiary care teaching hospital, over 18 months (Jan 2024–June 2025). Ethics approval obtained; informed consent from patients/guardians.

 

Study Population

Inclusion:

  • Adults ≥18 yrs,
  • acute OP poisoning within 24 hrs,
  • clinical features consistent with OP poisoning.


Exclusion:

  • Chronic exposure,
  • co-ingestion of other toxins,
  • terminal illness,
  • refusal of consent.

 

Sample Size Calculation

Based on previous study Kamath SD et al reporting 22% mortality, the minimum required sample size was calculated using formula : 263

A total of 276 patients were enrolled to account for  5% dropouts.¹

 

Data Collection

Demographics, mode and type of poisoning, clinical features, laboratory parameters, POP score at admission, interventions, complications, and outcomes were recorded using a structured proforma.

 

Management Protocol

Patients received standard treatment:

  • Gastric lavage and decontamination when appropriate
  • Atropine titrated to symptom resolution
  • Pralidoxime infusion when indicated
  • Supportive care including oxygen therapy and mechanical ventilation if needed

 

Statistical Analysis

  • Data analyzed in SPSS v25. Continuous variables: mean ± SD; categorical: n (%). χ², t-test, ANOVA, logistic regression used; p <0.05 significant.

 

 

 

 

 

 

Results

Demographics and Clinical Features

Table 1. Demographics and Clinical Characteristics (n=276)

Characteristic

n (%) or mean ± SD

Age (years)

32 ± 11

Male

102(58)

Female

116(42)

Suicidal ingestion

242(88)

Accidental ingestion

32(12)

Vomiting

243(88)

Profuse sweating

199(72)

Miosis

177(64)

Fasciculations

155(56)

Altered sensirium

105(38)

 

POP Severity and Ventilatory Support

Table 2. POP Severity and Ventilation Requirement

POP Severity

n (%)

Ventilatory Support n (%)

Mild (0–3)

105 (38)

13 (12)

Moderate (4–7)

119 (43)

55 (46)

Severe (8–11)

52 (19)

48 (92)

 

Treatment and Outcome

Table 3. Treatment and Outcomes

Parameter

n (%) or mean ± SD

Atropine use

276 (100)

Pralidoxime use

220 (80)

Mechanical ventilation

116 (42)

ICU admission

128 (46)

Mean hospital stay (days)

7.2 ± 4.3

Complications

86 (31)

Mortality

58 (21)

 

Table 4. Mortality According to POP Severity

POP Severity

Mortality n (%)

Mild

4 (4)

Moderate

19 (16)

Severe

35 (67)

 

Table 5. Logistic Regression for Mortality Predictors

Variable

OR (95% CI)

p-value

Severe POP score

8.5 (4.3–17.0)

<0.001

Mechanical ventilation

5.8 (2.8–12.0)

<0.001

Delay >6 hrs

4.0 (1.9–8.8)

0.002

 

Discussion

Organophosphorus (OP) compound poisoning remains a significant public health concern in developing countries, especially in rural agricultural regions, due to widespread availability and easy accessibility of these pesticides. In this study of 276 patients at HIMS Hassan, we observed a male predominance (58%) with a mean age of 32 ± 11 years. These findings are consistent with previous Indian studies such as Acharya et al.,¹¹ and Mevada et al.,³ which reported that young adults, particularly males, are at higher risk due to occupational exposure and intentional self-harm.

 

Suicidal ingestion accounted for 88% of cases, reflecting a socio-psychological pattern similar to that reported by Sah et al.,⁴ where most OP poisoning cases in rural India were intentional rather than accidental. This contrasts with studies from Iran and Sri Lanka, where accidental exposures constitute a larger proportion of cases.⁸,⁹

 

Clinical presentation in our cohort was dominated by vomiting (88%), profuse secretions (72%), miosis (64%), and fasciculations (56%). These findings align with the classical muscarinic and nicotinic manifestations described by Gupta et al.² and Mevada et al.³ Interestingly, 38% of our patients presented with altered sensorium, indicating central nervous system involvement, which is consistent with findings reported by Shadnia et al.⁸

 

The POP scale proved to be an effective predictor of severity and outcome. In our study, mild cases had a mortality of 4%, moderate cases 16%, and severe cases 67%. This is comparable to Kamath SD et al.,¹⁰ who reported overall mortality of 22% and demonstrated a significant correlation between POP scores and need for ventilatory support. Similarly, Chaudhary et al.,⁶ in a prospective study, emphasized that patients with higher POP scores were significantly more likely to require ICU care and mechanical ventilation.

 

Time to hospital presentation emerged as an independent predictor of mortality. Patients presenting more than 6 hours after ingestion had a fourfold increased risk of death, corroborating findings by Eddleston et al.,¹² who showed that early medical intervention significantly improves survival. This emphasizes the critical role of rapid transport and early resuscitation in OP poisoning management.

 

Type of OP compound ingested also influenced clinical severity. Monocrotophos and chlorpyrifos were the most common agents and were associated with higher rates of severe poisoning and ventilatory support, consistent with the findings of Regmi et al.⁷ and Shadnia et al.⁸ These organophosphates are highly toxic and associated with intermediate syndrome, respiratory failure, and cardiac complications. Intermediate syndrome occurred in 31% of patients in our study, similar to reports from other Indian centers.⁶

 

The need for mechanical ventilation in 42% of patients was comparable with prior studies, including Kamath SD et al.¹⁰ and Mevada et al.,³ highlighting the critical nature of respiratory involvement. Ventilatory support remains the cornerstone in severe OP poisoning and is directly associated with improved survival when provided promptly.

 

Our study also observed that delayed initiation of antidotes and supportive care contributed to poorer outcomes, echoing findings by Eddleston et al.¹² and Shadnia et al.⁸ Although biochemical markers such as serum cholinesterase were inconsistently available, clinical scoring systems like the POP scale provided practical and reliable prognostic information in resource-limited settings.⁷,⁹

 

When comparing with other international data, mortality rates vary widely. Studies from Sri Lanka reported mortality between 10–20%,⁷ while Iranian data reported rates up to 28% depending on the compound and supportive care availability.⁸ Our observed mortality of 21% aligns with these regional trends, reinforcing the importance of local epidemiological data to guide management strategies.

 

This study underscores several key clinical implications:

  1. Early identification of high-risk patients using the POP scale can guide ICU admission and mechanical ventilation decisions.
  2. Public health interventions to reduce pesticide availability and improve mental health support could reduce the burden of suicidal ingestion.
  3. Prompt hospital transfer and early antidote administration are critical for survival.

 

Limitations include the single-center design, lack of consistent biochemical monitoring, and absence of long-term follow-up to assess neurological or cognitive outcomes. Despite these limitations, our findings provide robust local data that can inform clinical protocols and regional health policies.

 

In summary, the POP score, time to hospital, and ventilatory requirement are strong predictors of mortality in OP poisoning. Comparison with prior studies including Kamath SD et al.,¹⁰ Mevada et al.,³ Chaudhary et al.,⁶ and Eddleston et al.¹² demonstrates consistency in trends and validates the use of clinical scoring in resource-limited settings.

 

Conclusion

POP scale severity at admission is a strong predictor of clinical outcome in OP poisoning. Early identification, timely antidote administration, and supportive care significantly reduce morbidity and mortality in tertiary care centers like HIMS Hassan.

 

Limitations

  1. Single-center study limits generalizability.
  2. Biochemical markers inconsistently available.
  3. Long-term neurological outcomes not assessed.
  4. Exact ingested quantity/type uncertain in some patients.

 

Future Directions

  • Multicenter studies with long-term follow-up.
  • Integration of biomarkers and electrophysiology for prognosis.
  • Community interventions on pesticide safety and mental health awareness.

 

REFERENCES

  1. Jeyaratnam J. Acute pesticide poisoning: a major global health problem. World Health Stat Q. 1990;43(3):139–44.
  2. Gupta SK, et al. Epidemiology of organophosphorus poisoning in India: A review. Indian J Crit Care Med. 2010;14(2):82–85.
  3. Mevada B, Parikh S, Chaudhari K, et al. Assess severity of organophosphate poisoning by Peradeniya Organophosphorus Poisoning (POP) scale. Indian J Forensic Med Toxicol. 2022;16(3):11–16.
  4. Sah SK, Das SK. Correlation between outcome and severity of organophosphorus poisoning. J Gen Pract Emerg Med Nepal. 2024;4:12–17.
  5. Saha DR, Islam N, Das S, et al. POP Score, glycemic status, and ECG changes and outcomes in OPC poisoning. Bangladesh J Medicine. 2025;34:56–63.
  6. Chaudhary S, Kalmegh R. Study of prognostic markers in organophosphorus poisoning. Int J Res Med Sci. 2018;6:4563–67.
  7. Regmi G, Arjyal B, Khanal K, et al. Correlation of POP scale and outcomes. Birat J Health Sci. 2020;5:43–50.
  8. Shadnia S, et al. Organophosphate poisoning in Iran: clinical features and outcomes. Hum Exp Toxicol. 2005;24:19–24.
  9. Eddleston M, et al. Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM. 2004;97:847–53.
  10. Kamath SD, Gautam VK, et al. Clinical profile and outcome of organophosphorus poisoning: a prospective study at Tata Main Hospital. J Family Med Prim Care. 2021;10:2005–10.
  11. Acharya A, et al. Sociodemographic and clinical features of organophosphorus poisoning in India. Indian J Emerg Med. 2019;9:34–40.
  12. Eddleston M, et al. Patterns and predictors of poisoning mortality in rural Asia. Clin Toxicol. 2008;46:150–9.

 

Recommended Articles
Original Article Open Access
The clinical efficacy of PRP injection in Tennis elbow: Is it worth the hype?
2026, Volume-7, Issue 1 : 75-79
DOI: 10.5281/zenodo.18188418
Original Article Open Access
EVALUATION OF THE COMBINED EFFECTS OF PIPERINE AND 5-FLUOROURACIL ON MG-63 OSTEOSARCOMA CELL LINES AN IN – VITRO STUDY
2026, Volume-7, Issue 1 : 93-98
Original Article Open Access
Outcomes of Primary PCI With Thrombus Aspiration Versus No Aspiration in Patients Presenting With ST-Elevation Myocardial Infarction (STEMI): A Comparative Study
2026, Volume-7, Issue 1 : 99-103
Original Article Open Access
Intra-Operative Surgical Difficulties in Women with Previous Two or More Cesarean Sections: A Prospective Observational Study from A Tertiary Care Centre
2026, Volume-7, Issue 1 : 88-92
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
22 Views
22 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved